None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Gender: Either male or non-pregnant, non-lactating female aged 18-60 years. 2) Subjects willing to give written informed consent 3) Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 4) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 5) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.
Exclusion criteria
Exclusion criteria: 1.Diabetic Patients. 2.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 3.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition. 4.Have open sores or open lesions in the treatment area(s). 5.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of such food product. 6.Have participated in any interventional clinical trial in the previous 30 days. 7.Have a known sensitivity to any of the constituents of the test product including sensitivities(mention some of active ingredient s name). 8.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids. 9.Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Glucose Assessment Day0(baseline), Day3, Day6 Timepoint: At t0(Baseline), t15min, t30min, t45min, t60min, t90min, and t120 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
CCFT Laboratories